D.-W. Kim

Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

Tony Mok, D. Ross Camidge, Shirish M. Gadgeel et al. · Annals of Oncology · 2020 · 686 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆

Jiaxin Niu, Corinne Maurice‐Dror, D.H. Lee et al. · Annals of Oncology · 2021 · 287 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Frank Griesinger, Giuseppe Curigliano, Michael Thomas et al. · Annals of Oncology · 2022 · 178 citations · Full text

Medicine, Oncology, Pharmacology +16

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

Martin Schüler, James Chih‐Hsin Yang, K. Park et al. · Annals of Oncology · 2015 · 132 citations · Full text

Medicine, Oncology, Pharmacology +13

Thin-film type Li-ion battery, using a polyethylene separator grafted with glycidyl methacrylate

Jang Myoun Ko, Booki Min, D.-W. Kim et al. · Electrochimica Acta · 2004 · 117 citations

Natural Sciences, Materials Engineering, Materials Science +16